23528367 19707851 19162340 24853936 21439944 24076336 23847585 29950970 20070435 17590238 21638071 31081015 34733131 30315879 20522014 33762004 26403791 19238406 21416019 29053874 32139977 34929160 28123806 35575872 - Search Results

Year	Number of Results
2007	1
2009	5
2010	2
2011	2
2013	3
2014	2
2015	2
2016	1
2017	1
2018	3
2019	1
2021	3
2022	2
2023	0

1

The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease.

Crimins JL, Pooler A, Polydoro M, Luebke JI, Spires-Jones TL. Crimins JL, et al. Ageing Res Rev. 2013 Jun;12(3):757-63. doi: 10.1016/j.arr.2013.03.002. Epub 2013 Mar 22. Ageing Res Rev. 2013. PMID: 23528367 Free PMC article. Review.

2

Recent advances in our understanding of neurodegeneration.

Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2009 Sep;116(9):1111-62. doi: 10.1007/s00702-009-0240-y. Epub 2009 Jun 5. J Neural Transm (Vienna). 2009. PMID: 19707851 Review.

3

Tau pathophysiology in neurodegeneration: a tangled issue.

Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT. Spires-Jones TL, et al. Trends Neurosci. 2009 Mar;32(3):150-9. doi: 10.1016/j.tins.2008.11.007. Epub 2009 Jan 21. Trends Neurosci. 2009. PMID: 19162340 Review.

4

The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Spires-Jones TL, Hyman BT. Spires-Jones TL, et al. Neuron. 2014 May 21;82(4):756-71. doi: 10.1016/j.neuron.2014.05.004. Neuron. 2014. PMID: 24853936 Free PMC article. Review.

5

T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.

Fukushima T, Nakamura A, Iwakami N, Nakada Y, Hattori H, Hoki S, Yamaguchi H, Nakagawa M, Terashima N, Narita H. Fukushima T, et al. Biochem Biophys Res Commun. 2011 Apr 22;407(4):730-4. doi: 10.1016/j.bbrc.2011.03.091. Epub 2011 Mar 31. Biochem Biophys Res Commun. 2011. PMID: 21439944

6

A role for tau at the synapse in Alzheimer's disease pathogenesis.

Pooler AM, Noble W, Hanger DP. Pooler AM, et al. Neuropharmacology. 2014 Jan;76 Pt A:1-8. doi: 10.1016/j.neuropharm.2013.09.018. Epub 2013 Sep 25. Neuropharmacology. 2014. PMID: 24076336 Review.

7

The importance of tau phosphorylation for neurodegenerative diseases.

Noble W, Hanger DP, Miller CC, Lovestone S. Noble W, et al. Front Neurol. 2013 Jul 1;4:83. doi: 10.3389/fneur.2013.00083. eCollection 2013. Front Neurol. 2013. PMID: 23847585 Free PMC article.

8

Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.

Chatterjee S, Mudher A. Chatterjee S, et al. Front Neurosci. 2018 Jun 8;12:383. doi: 10.3389/fnins.2018.00383. eCollection 2018. Front Neurosci. 2018. PMID: 29950970 Free PMC article. Review.

9

Basic mechanisms of neurodegeneration: a critical update.

Jellinger KA. Jellinger KA. J Cell Mol Med. 2010 Mar;14(3):457-87. doi: 10.1111/j.1582-4934.2010.01010.x. Epub 2010 Jan 11. J Cell Mol Med. 2010. PMID: 20070435 Free PMC article. Review.

10

Knock-out and transgenic mouse models of tauopathies.

Denk F, Wade-Martins R. Denk F, et al. Neurobiol Aging. 2009 Jan;30(1):1-13. doi: 10.1016/j.neurobiolaging.2007.05.010. Epub 2007 Jun 22. Neurobiol Aging. 2009. PMID: 17590238 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results